Insulet Corporation (PODD)

About Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

As of November 3, 2026, Insulet Corporation (PODD) stock rose to $156.32, up 1.76% (+$2.71) versus the previous close. On the day, shares have traded between $151.23 and $156.45. That puts PODD in the lower third of its 52-week range of $126.40 to $354.88. Insulet Corporation operates in the surgical & medical instruments & apparatus space and carries a market capitalization of roughly $10.65 billion, with about 427.2K shares changing hands.

Latest PODD news

• Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in LondonYahoo Finance· Nov 3, 7:00 AM ETGMT
• Insulet (PODD) Reports Next Week: Wall Street Expects Earnings GrowthYahoo Finance· Oct 28, 9:00 AM ET
• Insulet's Quarterly Earnings Preview: What You Need to Knowbarchart.com· Oct 27, 9:57 AM ET
• Insulet (PODD) Could Be 11% Undervalued On Omnipod Discover LaunchYahoo Finance· Oct 26, 2:07 AM ET
• DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT StudyYahoo Finance· Oct 20, 9:50 AM ET
• 2 Profitable Stocks to Keep an Eye On and 1 We QuestionYahoo Finance· Oct 19, 10:32 AM ET
• 2 of Wall Street’s Favorite Stocks to Target This Week and 1 We IgnoreYahoo Finance· Oct 16, 8:59 AM ET
• Insulet Announces Omnipod Discover Now Available in U.S.Yahoo Finance· Oct 12, 7:00 AM ET

Source: Yahoo Finance RSS · Updated November 3, 2026

Want PODD headlines, alerts and AI research in one place? Create a free account →

• Big support on $PODD monthly chart:

  @TradesWithTom· Oct 29, 3:27 PM ET

• $PODD 11/20 $155 call seeing nearly $1M in net buying. Reporting earnings on the morning of November 4th. ±12.15 implied move.

  @peloswing· Oct 29, 3:22 PM ET· Bullish

• $BBNX Going to be one of the best new product stories of 2027 in MedTech…buy every dip here. Headed to $30+. 🔥🦾 $DXCM $PODD $IHI $XLV

  @healthcareguru· Oct 29, 12:59 PM ET· Bullish

• 🎯 $PODD | BULLISH SETUP Healthcare / Medical Devices & Supplies 🐂 ⭐ Setup Quality Grade: A- 📌 Grade Justification: • Profitability: Premier Diabetes Tech Operator (~$10.4B market cap, $3.17B+ annual revenue, strong ~23.5% YoY top-line growth). • Revenue Growth: Omnipod …

  @OnlyFibs· Oct 28, 9:15 PM ET· Bullish

• The New Release. $PODD Like and Follow if you want more of this weekly!

  @MadMaverick· Oct 25, 12:04 AM ET· Bullish

Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →